Product Recalls in District of Columbia

Product recalls affecting District of Columbia — including food, drugs, consumer products, medical devices, and vehicles distributed to District of Columbia. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,655 recalls have been distributed to District of Columbia in the last 12 months.

47,654 total recalls
2,655 in last 12 months

Showing 24612480 of 13,355 recalls

DrugSeptember 21, 2022· Akorn, Inc.

Recalled Item: Rifampin Capsules Recalled by Akorn, Inc. Due to Failed...

The Issue: Failed impurities/degradation specifications: Finished product exceeds the 5...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 21, 2022· Akorn, Inc.

Recalled Item: Rifampin Capsules Recalled by Akorn, Inc. Due to Failed...

The Issue: Failed impurities/degradation specifications: Finished product exceeds the 5...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 20, 2022· QuVa Pharma, Inc.

Recalled Item: oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride...

The Issue: Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 19, 2022· UNICHEM PHARMACEUTICALS USA INC

Recalled Item: Clonidine Hydrochloride Tablets Recalled by UNICHEM PHARMACEUTICALS USA INC...

The Issue: Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 16, 2022· Novartis Pharmaceuticals Corporation

Recalled Item: Neoral soft gelatin capsules (cyclosporine capsules Recalled by Novartis...

The Issue: CGMP deviations: Out of specification results obtained during routine...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 16, 2022· ALMIRALL, LLC

Recalled Item: Xolegel (ketoconazole) gel 2% Recalled by ALMIRALL, LLC Due to Failed...

The Issue: Failed Viscosity specification: Slightly higher OOS results obtained for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 15, 2022· CIPLA

Recalled Item: Budesonide Inhalation Suspension 0.25mg/2mL Recalled by CIPLA Due to Lack of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 14, 2022· Dr. Reddy's Laboratories, Inc.

Recalled Item: Phytonadione Injectable Emulsion USP Recalled by Dr. Reddy's Laboratories,...

The Issue: Failed Stability Specifications: Out of specification results reported at...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 13, 2022· Lupin Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Lupin Pharmaceuticals Inc. Due to Foreign...

The Issue: Presence of Foreign Substance: Foreign material (metal piece) embedded in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 1, 2022· SUPERIOR GLOVE WORKS, LTD.

Recalled Item: Synergy Hand Sanitizer Recalled by SUPERIOR GLOVE WORKS, LTD. Due to CGMP...

The Issue: CGMP Deviations: FDA analysis found product to contain acetaldehyde impurity...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 31, 2022· Akorn, Inc.

Recalled Item: Lidocaine Hydrochloride Jelly USP Recalled by Akorn, Inc. Due to cGMP...

The Issue: cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 31, 2022· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Ointment USP Recalled by Akorn, Inc. Due to cGMP...

The Issue: cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 29, 2022· Teva Pharmaceuticals USA Inc

Recalled Item: Dextroamphetamine Saccharate Recalled by Teva Pharmaceuticals USA Inc Due to...

The Issue: Labeling: Label Error on Declared Strength; A sealed 100-count bottle...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 26, 2022· Carolina Infusion

Recalled Item: TRI-MIX 30/2/40 Injectable Recalled by Carolina Infusion Due to Lack of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 26, 2022· Carolina Infusion

Recalled Item: TRI-MIX 30/1/20 Injectable Recalled by Carolina Infusion Due to Lack of...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 26, 2022· Carolina Infusion

Recalled Item: MIC/B12/L-Carn (HD) 35/35/35/1/35 MG/ML Injectable Recalled by Carolina...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 26, 2022· Carolina Infusion

Recalled Item: TEST CYP/DHEA (Sesame) 200 MG/2.5 MG/ML Injectable Recalled by Carolina...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 26, 2022· Carolina Infusion

Recalled Item: QUAD-MIX 30/2/60/0.15 Injectable Recalled by Carolina Infusion Due to Lack...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 26, 2022· Carolina Infusion

Recalled Item: Semaglutide/Cyanocobalamin 24/2 MG/ML Injectable Recalled by Carolina...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 26, 2022· Carolina Infusion

Recalled Item: TEST CYP (Grapeseed) 200 MG/ML Injectable Recalled by Carolina Infusion Due...

The Issue: Lack of Assurance of Sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund